One-Year Results in Japanese Clinical Study Affirms the GORE VIABAHN Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease

News The device demonstrated excellent outcomes in treating long, complex lesions in the superficial femoral artery (SFA), achieving 88 percent primary patency at 12 months. The findings were presented during Vascular Interventional Advances 2016 in Las Vegas. Contributed Author:  W. L. Gore & Associates, Inc. Topics:  Cardiovascular